| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-05 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K67-0275 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01K67-027 |
| filingDate |
2003-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87a4085dcee6b77015312bb33dbe6bfa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e96c2b87651b7cb747cfaa7b8db37393 |
| publicationDate |
2004-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2004205831-A1 |
| titleOfInvention |
Transgenic SHIP2 animals and in vivo screening methods |
| abstract |
Transgenic animals comprising an alteration in the endogenous SH2 domain containing inositol 5-phosphatase (SHIP2), including both knock-in, knockouts, and knock-in/knockouts are described, as well as in vivo methods for identifying inhibitors of SHIP2. Such inhibitors are potential therapeutics for treatment of obesity and/or glucose intolerance resulting from a high fat diet. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2014284360-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2014284360-B9
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3016660-B1 |
| priorityDate |
2003-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |